Business Practice

Big pharma is turning to outside sources to fill pipelines, but how often are companies backing the wrong horse?

Rising drug prices are not helping the industry’s image problem.

Is pharma keeping up with the latest innovations? US legislators say no, and are looking to a new act to accelerate approvals.

Sitting Down With... Kiran Mazumdar-Shaw, Chairperson and Managing Director of Biocon, India.

In this paper, the authors describe the use of laser diffraction to analyse dry powder behaviour.

Paul Davies and Paul Kippax from Malvern Instruments examine how a QbD approach can inform analytical instrumentation design and manufacture...

In this article we look at the steps involved in moving from a drug substance to a successful oral solid dosage (OSD) form, and at the analytical technologies that can be helpful.

Sitting Down With… David Pyott, Former Chairman of the Board and Chief Executive Officer of Allergan, Inc.

When it comes to anti-counterfeiting, you need to go beyond legislation, think ahead, and harness the competitive edge that serialization can offer.

Tell us about the 2015 breakthrough products that are shaping the way you work.